These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9721172)

  • 21. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis.
    Mizuno F; Imai N; Yasuda K; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M; Kawashima H
    Intern Med; 2024 Jan; 63(1):57-61. PubMed ID: 37164665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Fatal Case of Toxic Epidermal Necrolysis Combined With Vanishing Bile Duct Syndrome and Hemophagocytic Lymphohistiocytosis.
    Wier J; Lacey A; Yenikomshian H; Gillenwater J
    J Burn Care Res; 2021 Sep; 42(5):1043-1046. PubMed ID: 33904918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis.
    Moradpour D; Altorfer J; Flury R; Greminger P; Meyenberger C; Jost R; Schmid M
    Hepatology; 1994 Dec; 20(6):1437-41. PubMed ID: 7982642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of vanishing bile duct syndrome with hyperlipidemia.
    Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F
    Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe cholestatic hepatitis associated with Stevens-Johnson syndrome after taking ibuprofen].
    Elkrief L; Chryssostalis A; Moachon L; Franck N; Terris B; Chaussade S; Sogni P
    Gastroenterol Clin Biol; 2007 Nov; 31(11):1043-5. PubMed ID: 18166906
    [No Abstract]   [Full Text] [Related]  

  • 27. Stevens-Johnson syndrome plus toxic hepatitis due to ibuprofen.
    Sternlieb P; Robinson RM
    N Y State J Med; 1978 Jul; 78(8):1239-43. PubMed ID: 276660
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug and toxin-induced bile duct disorders.
    Geubel AP; Sempoux CL
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1232-8. PubMed ID: 11129214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanishing bile duct syndrome in drug-induced liver disease.
    Desmet VJ
    J Hepatol; 1997; 26 Suppl 1():31-5. PubMed ID: 9138126
    [No Abstract]   [Full Text] [Related]  

  • 31. Lamotrigine-induced vanishing bile duct syndrome in a child.
    Bhayana H; Appasani S; Thapa BR; Das A; Singh K
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
    [No Abstract]   [Full Text] [Related]  

  • 32. Favourable long term effect of ursodeoxycholic acid treatment on congenital vanishing bile duct syndromes.
    Karageorgos SA; Tzardi M; Stratakou S; Voumvouraki A; Notas G; Kouroumalis E
    Acta Gastroenterol Belg; 2018; 81(2):330-332. PubMed ID: 30024707
    [No Abstract]   [Full Text] [Related]  

  • 33. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of toxic epidermal necrolysis and vanishing bile duct syndrome, requiring liver transplantation.
    Momen S; Dangiosse C; Wedgeworth E; Walsh S; Creamer D
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e450-e452. PubMed ID: 28426901
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome.
    Jakab SS; West AB; Meighan DM; Brown RS; Hale WB
    World J Gastroenterol; 2007 Dec; 13(45):6087-9. PubMed ID: 18023105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stevens-Johnson Syndrome and cholestatic hepatitis.
    Morelli MS; O'Brien FX
    Dig Dis Sci; 2001 Nov; 46(11):2385-8. PubMed ID: 11713940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Education and imaging. Hepatology: Rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen, requiring liver transplantation.
    Harimoto N; Wang H; Ikegami T; Takeishi K; Itoh S; Yamashita YI; Yoshizumi T; Aishima S; Shirabe K; Oda Y; Maehara Y
    J Gastroenterol Hepatol; 2015 Apr; 30(4):656. PubMed ID: 25776963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.